A new type of investigational therapeutic in development for pancreatic cancer has shown unprecedented tumor-fighting abilities in preclinical models of the disease, suggesting it has the potential to offer novel treatment options for nearly all pancreatic tumors, a comprehensive study has found.
Investigational therapeutic shows promise in preclinical pancreatic cancer model retrieved 8 April 2024 from https://medicalxpress.com/news/2024-04-therapeutic-preclinical-pancreatic-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.1 hour agoUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Investigational gene therapy shows promise for rare childhood neurodegenerative diseaseAn investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health.
続きを読む »
Investigational drug plozasiran shows promise in reducing severe hypertriglyceridemiaIn patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing any significant safety concerns, according to research presented at the American College of Cardiology's Annual Scientific...
続きを読む »
Clinical trial data show investigational cancer vaccine may elicit lasting immune response in pancreatic cancerNew data presented by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after...
続きを読む »
Investigational Testing on a New R&D System for Continuous Granulation and DryingThis article discusses the investigational testing on a new R&D system (QbCon® 1) that provides continuous granulation and drying, focusing on the dryer and the granules produced. The dryer achieved extremely narrow and duplicatable residence time distributions, resulting in dissimilar size classifications of granules that dried uniformly.
続きを読む »
Experimental gene therapy for giant axonal neuropathy shows promise in clinical trialAn investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health (NIH).
続きを読む »
Clinical trial data show investigational cancer vaccine may elicit lasting immune response in pancreatic cancerNew data presented by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate, autogene cevumeran, continues to show potential to stimulate an immune response that may reduce the risk of the disease returning after...
続きを読む »